The authors investigated a polymorphism of the regulatory region of the serotonin transporter gene in a well-characterized sample of in-patients and healthy controls. They found that carriers of a particular allele not only made more suicide attempts over time, but also displayed an enhancement of some aspects of the suicidal gesture-like violence, lethality and intent. These observations are remarkable because they are independent of the clinical diagnosis and, also, the demographic and sociocultural parameters investigated.
IMMEDIATE COMMUNICATION
Polymorphisms in the untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression J Duan, AR Sanders, JEV Molen, L Martinolich, BJ Mowry, DF Levinson, RR Crowe, JM Silverman, PV Gejman
The authors present evidence of complex balancing regulation of HTR1B transcription by common polymorphisms in its promoter. They found that T-261G and A-161T exhibit allelic variation of HTR1B expression and differential binding of transcriptional factors. The representation of functional haplotypes in the population had also been evaluated. The results indicate that HTR1B is the target of substantial transcriptional genetic regulation by common haplotypes.
ORIGINAL RESEARCH ARTICLE
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia SJ Glatt, SV Faraone, MT Tsuang
The D2 subtype of dopamine receptor has been widely implicated in the pathogenesis of schizophrenia. Early evidence supporting an association between the Cys311Ser polymorphism of the D2 receptor gene (DRD2) and schizophrenia was subsequently refuted and, eventually, dismissed. From all 24 published case-control studies, the authors calculated the pooled estimate of this association to be 1.3 for the Cys allele, which was highly significant (P¼0.007). The results provide strong evidence that DRD2 influences susceptibility to schizophrenia.
Examination of AVPR1a as an autism susceptibility gene TH Wassink, J Piven, VJ Vieland, J Pietila, RJ Goedken, SE Folstein, VC Sheffield Impaired social interaction is a core feature of autism, and the arginine-vasopressin (AVP) hormonal system strongly influences social behavior. Therefore, the authors tested whether the AVP1a gene (AVPR1a) contributes to autism susceptibility. While they found no coding sequence changes that clearly contributed to autism, they did identify nonrandom transmission of alleles from nearby polymorphisms. This supports previous findings and indicates that AVPR1a and other genes in the AVP system remain strong candidates for involvement in autism susceptibility.
Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene E Bacchelli, F Blasi, M Biondolillo, JA Lamb, E Bonora, G Barnby, J Parr, KS Beyer, SM Klauck, A Poustka, AJ Bailey, AP Monaco, E Maestrini, International Molecular Genetic Study of Autism Consortium (IMGSAC)
The authors tested nine functional candidate genes for predisposition to autism in a region on chromosome 2, a region previously linked to the disorder. Several variants were detected in all genes tested. Most interestingly, four rare nonsynonymous variants were found in the cAMP-GEFII gene, which were absent from a large population of controls. Further investigations will be needed to clarify the contribution of cAMP-GEFII gene variants to autism susceptibility.
Selectively bred Wistar Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants CC Will, F Aird, EE Redei
The Wistar Kyoto (WKY) rat strain is a genetic animal model of depression, and harbors behavioral and genetic variability not found in other inbred strains. Taking advantage of this, the authors selectively bred WKY for 'depressive' behavior in the forced swim test. The WKY 'most immobile' and 'least immobile' substrains differ in behavior, hormonal stress response, and sensitivity to antidepressants, making them a useful animal model to explore the molecular mechanisms of depressive behavior and antidepressant sensitivity.
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype N Ozaki, D Goldman, WH Kaye, K Plotnicov, BD Greenberg, J Lappalainen, G Rudnick, DL Murphy A mutation in the serotonin transporter, the primary site of action of drugs like fluoxetine, was found in seven members of two unrelated families. Of the seven members, six had OCD or OC personality disorder and four had other severe disorders like Asperger's Syndrome and anorexia nervosa. The mutation alters the function and regulation of the transporter; therefore, it may be a contributing factor in a subtype of OCD with complex comorbidity.
An M129V variation in the prion protein may influence cognitive performance D Rujescu, AM Hartmann, C Gonnermann, H-J Möller, I Giegling Brain white matter volume and IQ correlate due to genetic factors. The authors have previously found that an M129V variation in the prion protein influences white-matter volume. Now, they studied the influence of this variation on IQ. The polymorphism was associated with full-scale IQ and the most significant association was with the digit symbol subtest. This is the first study that associates a common genetic variation in the prion protein gene with cognitive performance.
